{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:56:58Z","timestamp":1775728618156,"version":"3.50.1"},"reference-count":27,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,12,8]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Radiotherapy modalities such as iodine-125 (I\n                      <jats:sup>125<\/jats:sup>\n                      ) and ruthenium-106 (Ru\n                      <jats:sup>106<\/jats:sup>\n                      ) brachytherapy and proton beam radiotherapy (PBR) are well established for the treatment of choroidal melanoma. This study aimed to evaluate the rates of local tumour control, globe retention and visual acuity (VA) outcomes in patients with choroidal melanoma treated with I\n                      <jats:sup>125<\/jats:sup>\n                      or Ru\n                      <jats:sup>106<\/jats:sup>\n                      brachytherapy or PBR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      A review was conducted of all cases of choroidal melanoma treated with Ru\n                      <jats:sup>106<\/jats:sup>\n                      or I\n                      <jats:sup>125<\/jats:sup>\n                      brachytherapy or PBR over a 10-year period. Patient demographics, comorbidities, tumour characteristics, treatment parameters and VA outcomes were analysed. A predictive nomogram was developed to estimate final VA based on baseline clinical, tumour and radiation parameters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 310 eyes from 310 patients were included, comprising 175 patients (56.5%) treated with Ru\n                      <jats:sup>106<\/jats:sup>\n                      , 72 (23.2%) treated with I\n                      <jats:sup>125<\/jats:sup>\n                      brachytherapy and 63 (20.3%) treated with PBR. Local tumour control was achieved in 95.8% of cases. The recurrence rates were 4.0%, 4.2% and 4.8% for Ru\n                      <jats:sup>106<\/jats:sup>\n                      , I\n                      <jats:sup>125<\/jats:sup>\n                      and PBR, respectively. Retention rates were 96.0% for Ru\n                      <jats:sup>106<\/jats:sup>\n                      , 94.4% for I\n                      <jats:sup>125<\/jats:sup>\n                      and 95.2% for PBR. LogMAR VA of 1.0 or better was maintained in 50.9% of Ru\n                      <jats:sup>106<\/jats:sup>\n                      patients, 27.8% of I\n                      <jats:sup>125<\/jats:sup>\n                      patients and 39.7% of those treated with PBR. Baseline LogMAR VA, tumour volume, radiation dose to the fovea, radiotherapy modality and follow-up duration were significant predictors of final VA and were incorporated into the nomogram.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Each radiotherapy modality demonstrated high rates of local tumour control and globe retention. The predictive nomogram may serve as a practical tool to support individualised visual prognostication and patient counselling in the management of choroidal melanoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2025-002291","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:00:14Z","timestamp":1767772814000},"page":"e002291","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Tumour control, eye retention and visual acuity after radiotherapy for choroidal melanoma"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1892-459X","authenticated-orcid":false,"given":"Patrick","family":"Murtagh","sequence":"first","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland"},{"name":"Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland"},{"name":"Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK"},{"name":"Department of Radiation Oncology, St. Luke\u2019s Hospital, Dublin, Ireland"},{"name":"UCD School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1268-7423","authenticated-orcid":false,"given":"Matthew M","family":"O\u2019Riordan","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland"},{"name":"Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moya","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, St. Luke\u2019s Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"D\u2019Arcy","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Eleuteri","sequence":"additional","affiliation":[{"name":"Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Greene","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Baily","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland"},{"name":"Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland"},{"name":"National Ophthalmic Pathology Laboratory of Ireland\u2014Royal Victoria Eye and Ear Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumana","family":"Hussain","sequence":"additional","affiliation":[{"name":"Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Heimann","sequence":"additional","affiliation":[{"name":"Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Horgan","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland"},{"name":"Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland"},{"name":"Department of Radiation Oncology, St. Luke\u2019s Hospital, Dublin, Ireland"},{"name":"UCD School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"2026010700000863000_11.1.e002291.1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309034"},{"key":"2026010700000863000_11.1.e002291.2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye (Lond)"},{"key":"2026010700000863000_11.1.e002291.3","doi-asserted-by":"crossref","first-page":"926034","DOI":"10.3389\/fmed.2022.926034","article-title":"Trends in Uveal Melanoma Presentation and Survival During Five Decades: A Nationwide Survey of 3898 Swedish Patients","volume":"9","author":"Gill","year":"2022","journal-title":"Front Med"},{"key":"2026010700000863000_11.1.e002291.4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026010700000863000_11.1.e002291.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-021-01001-w","article-title":"Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part II: treatment indications and complications","volume":"12","author":"Foti","year":"2021","journal-title":"Insights Imaging"},{"key":"2026010700000863000_11.1.e002291.6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s11864-024-01212-5","article-title":"External Beam Radiotherapy in the Management of Uveal Melanoma","volume":"25","author":"Yilmaz","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"2026010700000863000_11.1.e002291.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.003"},{"key":"2026010700000863000_11.1.e002291.8","doi-asserted-by":"crossref","unstructured":"Steyerberg E , Harrell FE . Regression modeling strategies: with applications, to linear models, logistic and ordinal regression, and survival analysis. Heidelberg: Springer: Oxford University Press, 2016.","DOI":"10.1007\/978-3-319-19425-7"},{"key":"2026010700000863000_11.1.e002291.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.10.026"},{"key":"2026010700000863000_11.1.e002291.10","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4076(81)90062-2"},{"key":"2026010700000863000_11.1.e002291.11","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1080\/03610920601126589","article-title":"Inference Under Heteroskedasticity and Leveraged Data","volume":"36","author":"Cribari-Neto","year":"2007","journal-title":"Communications in Statistics - Theory and Methods"},{"key":"2026010700000863000_11.1.e002291.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.11.021"},{"key":"2026010700000863000_11.1.e002291.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90456-6"},{"key":"2026010700000863000_11.1.e002291.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-022-02521-9","article-title":"Ruthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results","volume":"22","author":"Mirshahi","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"2026010700000863000_11.1.e002291.15","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302490"},{"key":"2026010700000863000_11.1.e002291.16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.radonc.2021.01.030","article-title":"Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma","volume":"157","author":"van Beek","year":"2021","journal-title":"Radiother Oncol"},{"key":"2026010700000863000_11.1.e002291.17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ajo.2015.08.034","article-title":"Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis","volume":"160","author":"Fabian","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"2026010700000863000_11.1.e002291.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-022-02387-x","article-title":"Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"2026010700000863000_11.1.e002291.19","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1986.01050190067041"},{"key":"2026010700000863000_11.1.e002291.20","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-01621-4","article-title":"106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma","volume":"15","author":"Jiang","year":"2020","journal-title":"Radiat Oncol"},{"key":"2026010700000863000_11.1.e002291.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.02.059"},{"key":"2026010700000863000_11.1.e002291.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00526-1"},{"key":"2026010700000863000_11.1.e002291.23","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.9.1219"},{"key":"2026010700000863000_11.1.e002291.24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/jamaophthalmol.2017.3805","article-title":"Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas","volume":"135","author":"Papakostas","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2026010700000863000_11.1.e002291.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90455-4"},{"key":"2026010700000863000_11.1.e002291.26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000534184","article-title":"Outcomes after Proton Beam Irradiation in Patients with Choroidal Melanoma Eligible for Investigational AU-011 Treatment","volume":"9","author":"Wu","year":"2023","journal-title":"Ocul Oncol Pathol"},{"key":"2026010700000863000_11.1.e002291.27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3928\/1542-8877-19950901-13","article-title":"Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy","volume":"26","author":"Summanen","year":"1995","journal-title":"Ophthalmic Surg Lasers"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2025-002291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:00:18Z","timestamp":1767772818000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2025-002291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,6]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjophth-2025-002291"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2025-002291","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}